MSNews updates are on hold until further notice. Sign-up on our mailing list here to be notified when we are back.
September 14, 2008
The latest issue of the Accelerated Cure Project print newsletter is available for download as a PDF. Feature article is on Vitamin D and MS.
Here's some more info on the FDA response to the two new cases of PML with Tysabri. Not sure what this does beyond all the warnings you get when enrolling in the TOUCH program, but hey, somebody needed to do something I guess. A PDF of the new prescribing info is here.
On the flip side, here's a study modeling the long-term risks and benefits of natalizumab in individuals with relapsing multiple sclerosis that concludes that a more than sevenfold increase in actual risk of progressive multifocal leukoencephalopathy was required to decrease natalizumab's health gain below that of interferon beta-1a.

